Mark Burish is a Neurology physician affiliated with Baylor College of Medicine. OpenAlex indexes 78 publications with 2,328 citations (h-index 27); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6400 Fannin St Ste 2010
Houston, TX 770301545
Telephone
713-486-7770Provider last certified this registry record 10 Feb 2020.
Clinical trials
- Zavegepant Intranasal Spray for the Acute Treatment of Episodic Cluster Headache
Sponsor: The University of Texas Health Science Center, Houston
- Cluster Headache Treatment Survey
Sponsor: The University of Texas Health Science Center, Houston
- High Dose Vitamin D Plus Multivitamin in the Prevention of Cluster Headache
Sponsor: The University of Texas Health Science Center, Houston
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment$10,125openpaymentsdata.cms.gov ↗
- H. Lundbeck A SProgram year20241 payment
- Lundbeck LLCProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
77.6%Calcitonin Gene-related Peptide Receptor Antagonist13.1%Ubrelvy57%Nurtec Odt24%Qulipta20%Part D<11 patientsGabapentinoids12.7%Gabapentin55%Pregabalin46%Part D≥28 patients+ 11 more classes in this area
Musculoskeletal
14.1%Muscle Relaxant5.8%Cyclobenzaprine Hcl59%Methocarbamol41%Part D<11 patientsNonsteroidal Anti-inflammatory Drug3.1%Indomethacin100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
4.9%Beta blocker2%Propranolol Hcl100%Part D<11 patientsAngiotensin receptor blocker (ARB)1.7%Candesartan Cilexetil100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2024–2026 per NIH RePORTER. The latest:
- Regulation of headache pain responses by the Trigeminal ganglion clock
University of Texas Hlth Sci Ctr Houston
FY2026$485,692R01NS136677 - Development of a multi-modal mouse model of cluster headache
University of Texas Hlth Sci Ctr Houston
FY2026$392,223R61NS144491 - Regulation of headache pain responses by the Trigeminal ganglion clock
University of Texas Hlth Sci Ctr Houston
FY2025$437,472R01NS136677
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity
The Journal of Headache and Pain
2025 - Regulation of headache response and transcriptomic network by the trigeminal ganglion clock
Headache The Journal of Head and Face Pain
2024 - Photophobia is associated with lower sleep quality in individuals with migraine: results from the American Registry for Migraine Research (ARMR)
The Journal of Headache and Pain
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
William Mitch, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”